Nothing Special   »   [go: up one dir, main page]

NO20054535L - Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme - Google Patents

Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme

Info

Publication number
NO20054535L
NO20054535L NO20054535A NO20054535A NO20054535L NO 20054535 L NO20054535 L NO 20054535L NO 20054535 A NO20054535 A NO 20054535A NO 20054535 A NO20054535 A NO 20054535A NO 20054535 L NO20054535 L NO 20054535L
Authority
NO
Norway
Prior art keywords
heterocyclic compounds
processes
preparation
same
bifunctional heterocyclic
Prior art date
Application number
NO20054535A
Other languages
English (en)
Other versions
NO20054535D0 (no
Inventor
Jay J Farmer
Joyce A Sutcliffe
Ashoke Bhattacharjee
Original Assignee
Rib X Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rib X Pharmaceuticals Inc filed Critical Rib X Pharmaceuticals Inc
Publication of NO20054535D0 publication Critical patent/NO20054535D0/no
Publication of NO20054535L publication Critical patent/NO20054535L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en familie av bifunksjonelle heterocykliske forbindelser anvendelige som antiinfeksjons-, antiproliferative, antiinflammasjons- og pro-kinetiske midler. Oppfinnelsen tilveiebringer også fremgangsmåte for fremstilling av de bifunksjonelle heterocykliske forbindelsene og fremgangsmåter for anvendelse av slike forbindelser som antiinfektive midler, antiproliferative midler, antiinflammasjonsmidler og/eller prokinetiske midler.
NO20054535A 2003-03-05 2005-10-03 Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme NO20054535L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45195103P 2003-03-05 2003-03-05
PCT/US2004/006892 WO2004078770A1 (en) 2003-03-05 2004-03-05 Bifunctional heterocyclic compounds and methods of making and using the same

Publications (2)

Publication Number Publication Date
NO20054535D0 NO20054535D0 (no) 2005-10-03
NO20054535L true NO20054535L (no) 2005-11-25

Family

ID=32962667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054535A NO20054535L (no) 2003-03-05 2005-10-03 Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme

Country Status (11)

Country Link
US (1) US20070072811A1 (no)
EP (1) EP1599491A1 (no)
JP (1) JP2006523229A (no)
KR (1) KR20060002800A (no)
CN (1) CN1780846A (no)
AU (1) AU2004217919A1 (no)
BR (1) BRPI0408117A (no)
CA (1) CA2517970A1 (no)
MX (1) MXPA05009430A (no)
NO (1) NO20054535L (no)
WO (1) WO2004078770A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682563A1 (en) * 2003-10-30 2006-07-26 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same
WO2005049632A1 (en) * 2003-11-18 2005-06-02 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
WO2005085266A2 (en) 2004-02-27 2005-09-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP1928893A2 (en) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
BRPI0617824A2 (pt) 2005-10-28 2011-08-09 Nestec Sa métodos para o uso de aminoácidos de cadeia ramificada
EP2177526A4 (en) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
US8927551B2 (en) 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
CN101857617A (zh) * 2010-04-28 2010-10-13 中国海洋大学 喹唑啉类糖衍生物及其制备方法和应用
AU2015346023A1 (en) 2014-11-14 2017-06-01 Melinta Subsidiary Corp. Method for treating, preventing, or reducing the risk of skin infection

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544451A (en) * 1895-08-13 Roller-bearing for carriage-spindles
US3629232A (en) * 1969-08-19 1971-12-21 Abbott Lab 2'-o-alkanoyl-4'-alkanoyloxy derivatives of erythromycin
US3681325A (en) * 1970-09-30 1972-08-01 Abbott Lab De(n-methyl)-n-substituted derivatives of erythromycin
US4404201A (en) * 1981-11-13 1983-09-13 Warner-Lambert Company Cephalosporins
US4546176A (en) * 1982-12-14 1985-10-08 Eisai Co., Ltd. 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US6446032B1 (en) * 1990-09-21 2002-09-03 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid by binding to the minor groove
CA2120493A1 (en) * 1991-10-01 1993-04-15 Ronald E. White Process for making antimicrobial quinolonyl lactams
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
ES2178093T5 (es) * 1995-11-17 2009-02-16 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Derivados de epotilon y su preparacion.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US6437119B1 (en) * 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6288234B1 (en) * 1998-06-08 2001-09-11 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
US6355810B1 (en) * 1998-06-08 2002-03-12 Advanced Medicine, Inc. Multibinding inhibitors of HMG-CoA reductase
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
EP1085845A2 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Multibinding inhibitors of cyclooxygenase-2
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6479498B1 (en) * 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
HRP990192A2 (en) * 1999-06-11 2001-04-30 Pliva D D 4'-DEMICAROZYL-8a-AZA-8a-HOMOTHILOSINE DERIVATIVES
US6921810B2 (en) * 2000-04-27 2005-07-26 The Scripps Research Institute Bifunctional antibiotics
AU2002329785A1 (en) * 2001-08-17 2003-03-03 The Trustees Of Princeton University Bifunctional glycopeptides antibiotics and combinatorial libraries thereof
US6576615B2 (en) * 2001-11-08 2003-06-10 Enanta Pharmaceuticals, Inc. 4′-O-substituted tylosin analogs
US6664240B2 (en) * 2001-11-15 2003-12-16 Enanta Pharmaceuticals, Inc. Tylosin derivatives having antibacterial activity
CA2469665A1 (en) * 2002-01-22 2003-07-31 Pharmacia & Upjohn Company Infection-resistant medical devices
US6710034B2 (en) * 2002-04-19 2004-03-23 Enanta Pharmaceuticals, Inc. 5-O-mycaminosyltylonide derivatives
US6753415B2 (en) * 2002-04-19 2004-06-22 Enanta Pharmaceuticals, Inc. 23-O-substituted 5-O-mycaminosyltylonide derivatives
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
EP1509538A1 (en) * 2002-05-13 2005-03-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
BR0312634A (pt) * 2002-07-08 2005-05-10 Pliva Istrazivacki Inst D O O Novos compostos, composições e métodos para tratamento de doenças e condições inflamatórias
PL375162A1 (en) * 2002-07-08 2005-11-28 Pliva-Istrazivacki Institut D.O.O. Novel compounds, compositions as carriers for steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
RS20050007A (en) * 2002-07-08 2007-09-21 Glaxo Smith Kline Istraživački Centar Zagreb D.O.O., Novel nonsteroidal anti- inflammatory substances, compositions and methods for their use
AR043050A1 (es) * 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
EP1682563A1 (en) * 2003-10-30 2006-07-26 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same

Also Published As

Publication number Publication date
JP2006523229A (ja) 2006-10-12
CN1780846A (zh) 2006-05-31
CA2517970A1 (en) 2004-09-16
NO20054535D0 (no) 2005-10-03
BRPI0408117A (pt) 2006-03-01
EP1599491A1 (en) 2005-11-30
AU2004217919A1 (en) 2004-09-16
MXPA05009430A (es) 2006-04-07
US20070072811A1 (en) 2007-03-29
WO2004078770A1 (en) 2004-09-16
KR20060002800A (ko) 2006-01-09

Similar Documents

Publication Publication Date Title
TW200420573A (en) Bifunctional heterocyclic compounds and methods of making and using same
ATE433447T1 (de) Pyrimiidinverbindungen
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
UY28348A1 (es) Compuestos novedosos
AP2006003514A0 (en) Piperazine derivatives for the treatment of HIV infections.
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ITRM20040015A1 (it) Procedimento per la composizione di un rivestimento nanocomposito.
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
WO2005085266A3 (en) Macrocyclic compounds and methods of making and using the same
DK1879580T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet
DK1879581T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet
NO20050019L (no) Polytylenglykolaldehyd-derivater
DE502006004524D1 (de) Verfahren zur herstellung von 3,7-diaza-bicycloä3.3.1ünonan-verbindungen
NO20053473L (no) Fremgangsmate for fremstilling av R,R (eller S,S) konfigurasjonen av glykopyrroniumstereoisomerer
WO2004050613A3 (en) 2-substituted-3-propenamide derivatives and methods of using the same
ATE274515T1 (de) Pyrazolopyridinderivate
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
ATE391489T1 (de) Haarbehandlungszusammensetzungen
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner